Diabetes Grand Challenge awards $3.57 million for insulin research
The London-based Type 1 Diabetes Grand Challenge—a partnership between the Steve Morgan Foundation, the British Diabetic Association (Diabetes UK), and the Juvenile Diabetes Research Foundation (JDRF UK)—has announced six grants totaling £2.7 million ($3.57 million) in support of research and development of ultra-rapid, smart, and precision insulins.
The grants are part of the Grand Challenge’s £15 million ($19.85 million) push to accelerate the science of insulins that more closely mimic a healthy pancreas, improving the lives of people living with type 1 diabetes. Grant recipients include Indiana, Stanford, and Wayne State universities and the University of Notre Dame—all in the United States—as well as Monash University (Australia) and the Jinhua Institute of Zhejiang University (China).
“By imagining a world where insulins can respond to changing glucose levels in real-time, we hope these six projects will help to create [a] new reality, relieving people with type 1 of the relentless demands that living with this condition places on them today,” said JDRF UK director of research partnerships Rachel Connor.
“This unique funding is transforming the ability of global scientists to join forces to tackle type 1 diabetes,” said Grand Challenge scientific advisory panel chair Simon Heller. “It enables researchers to set up new collaborations and to test innovative ideas, which may lead to a step change in finding a cure.”
(Photo credit: Getty Images/Rich Legg)
Related content
PCORI announces $165 million in health research grants
Helmsley Charitable Trust awards $12 million for T1D and exercise
